List of works - Min Shi

An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression

scientific article published on 20 March 2017

Biomarker discovery in neurodegenerative diseases: a proteomic approach.

scientific article

CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease

scientific article published on 24 May 2016

CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment.

scientific article

CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease

scientific article

Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation.

scientific article

Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control

scientific article

Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy

scientific article

Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ₄₂ using Meso Scale Discovery Assays for Alzheimer's Disease

scientific article

Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease.

scientific article published on 2 March 2014

Four new monomeric insulins obtained by alanine scanning the dimer-forming surface of the insulin molecule

scientific article published on 01 November 2000

Glycoproteomics in neurodegenerative diseases

scientific article

Identification of ciliary neurotrophic factor receptor alpha as a mediator of neurotoxicity induced by alpha-synuclein

scientific article

Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression

scientific article

Identification of proteins in human substantia nigra

scientific article published on May 2008

Identification of synaptosomal proteins binding to monomeric and oligomeric α-synuclein.

scientific article published on 6 February 2015

Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease

scientific article published on 04 May 2013

Mass-Spectrometry-Based Method To Quantify in Parallel Tau and Amyloid β 1-42 in CSF for the Diagnosis of Alzheimer's Disease

scientific article published on 23 January 2017

Mortalin: a protein associated with progression of Parkinson disease?

scientific article

Phosphorylated α-synuclein in Parkinson's disease: correlation depends on disease severity

scientific article

Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.

scientific article

Proteomic analysis of saliva from patients with oral chronic graft-versus-host disease

scientific article

Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease

scientific article

Proteomic profiling in MPTP monkey model for early Parkinson disease biomarker discovery

scientific article published on 22 January 2015

Quantitative Characterization of Glycoproteins in Neurodegenerative Disorders Using iTRAQ ⬇️

scientific article published on January 1, 2013

Quantitative proteomic analysis of oligodendrogliomas with and without 1p/19q deletion

scientific article

Rab11a and HSP90 regulate recycling of extracellular alpha-synuclein

scientific article published on February 2009

SNCA variant associated with Parkinson disease and plasma alpha-synuclein level

scientific article

Salivary Tau Species are Potential Biomarkers of Alzheimer's Disease ⬇️

scientific article published on January 1, 2011

Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease.

scientific article published on 24 February 2011

Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.

scientific article

Targeted discovery and validation of plasma biomarkers of Parkinson's disease

scientific article

Tau Proteins Cross the Blood-Brain Barrier

scientific article published on 20 September 2016

Transcriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson's Disease

scientific article

α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment

scientific article published on January 2013

List of works by Min Shi

An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression

Biomarker discovery in neurodegenerative diseases: a proteomic approach.

CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease

CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment.

CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease

Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation.

Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control

Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy

Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ₄₂ using Meso Scale Discovery Assays for Alzheimer's Disease

Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease.

Four new monomeric insulins obtained by alanine scanning the dimer-forming surface of the insulin molecule

Glycoproteomics in neurodegenerative diseases

Identification of ciliary neurotrophic factor receptor alpha as a mediator of neurotoxicity induced by alpha-synuclein

Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression

Identification of proteins in human substantia nigra

Identification of synaptosomal proteins binding to monomeric and oligomeric α-synuclein.

Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease

Mass-Spectrometry-Based Method To Quantify in Parallel Tau and Amyloid β 1-42 in CSF for the Diagnosis of Alzheimer's Disease

Mortalin: a protein associated with progression of Parkinson disease?

Phosphorylated α-synuclein in Parkinson's disease: correlation depends on disease severity

Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.

Proteomic analysis of saliva from patients with oral chronic graft-versus-host disease

Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease

Proteomic profiling in MPTP monkey model for early Parkinson disease biomarker discovery

Quantitative Characterization of Glycoproteins in Neurodegenerative Disorders Using iTRAQ ⬇️

Quantitative proteomic analysis of oligodendrogliomas with and without 1p/19q deletion

Rab11a and HSP90 regulate recycling of extracellular alpha-synuclein

SNCA variant associated with Parkinson disease and plasma alpha-synuclein level

Salivary Tau Species are Potential Biomarkers of Alzheimer's Disease ⬇️

Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease.

Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.

Targeted discovery and validation of plasma biomarkers of Parkinson's disease

Tau Proteins Cross the Blood-Brain Barrier

Transcriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson's Disease

α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment